Volume 12 - Issue 9 - September 2004

O ne product presently used for soft tissue augmentation in Europe is Sculptra (NewFill). Unlike many other fillers, this product does not itself cause soft tissue augmentation by directly replacing lost tissue. Rather, it stimulates collagen growth from innate fibroblasts. As with any new material, there will be many questions in the beginning, and I predict that the knowledge will be viral when the material is introduced into the United States. Sculptra is made from lactic acid — a substance that is familiar to dermasurgeons who have used vicryl sutures. It has been used for years in Eur